# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001013596-10-000075
Filing Date
2010-08-04
Accepted
2010-08-03 18:51:08
Documents
20
Period of Report
2010-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10Q FOR QUARTER ENDED JUNE 30, 2010 | fm10q_3-10.htm | 10-Q | 369406
2 | STATEMENT OF SHARE AND EQUITY CAPITAL EXCHANGE | exh3-4.htm | EX-3.4 | 789
3 | ARTICLES OF AMENDMENT TO ARTICLES OF INCORPORATION | exh3-5.htm | EX-3.5 | 1129
4 | CERTIFICATION OF CHIEF EXECUTIVE OFFICER | exh31-1.htm | EX-31.1 | 16220
5 | CERTIFICATION OF CHIEF FINANCIAL OFFICER | exh31-2.htm | EX-31.2 | 16218
6 | CERTIFICATION OF CHIEF EXECUTIVE AND CHIEF FINANCIAL OFFICERS | exh32.htm | EX-32 | 8056
7 |  | sun-img2.jpg | GRAPHIC | 22731
8 |  | sun-img3.jpg | GRAPHIC | 11304
9 |  | sun-img1.jpg | GRAPHIC | 15856
10 |  | sunaoa1a.jpg | GRAPHIC | 70545
11 |  | sun-aoa5.jpg | GRAPHIC | 63746
12 |  | sun-aoa7.jpg | GRAPHIC | 83825
13 |  | sun-aoa8.jpg | GRAPHIC | 47713
14 |  | sunaoa6a.jpg | GRAPHIC | 90782
15 |  | sunsaoa2a.jpg | GRAPHIC | 40729
16 |  | sunaoa3a.jpg | GRAPHIC | 17278
17 |  | sunsaoa4a.jpg | GRAPHIC | 69552
18 |  | sunsse1a.jpg | GRAPHIC | 47012
19 |  | sunsse2a.jpg | GRAPHIC | 46607
20 |  | sunsse3a.jpg | GRAPHIC | 45691
| Complete submission text file | 0001013596-10-000075.txt |  | 1342895

Mailing Address 6100 ROYALMOUNT AVENUE MONTREAL A8 H4P 2R2
Business Address 6100 ROYALMOUNT AVENUE MONTREAL A8 H4P 2R2 514-496-5197
Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)

EIN.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52898 | Film No.: 10989042
SIC: 8742 Services-Management Consulting Services